We report a case of severe tinea capitis, treated successfully with griseofulvin. In our opinion, the treatment of this severe dermatophytosis with griseofulvin is safe and effective. Other treatments, such as itraconazole pulsed therapy, failed, despite an initial improvement, leading to an aggressive recurrence of the lesion. We chose griseofulvin for its well-known large spectrum activity, also against uncommon species, like Microsporum Gypseum, which are responsible for the most severe cases.
ZaraaIHawiloAAounallahATrojjetSEl EuchDMokniMOsmanAB. Inflammatory tinea capitis: a 12-year study and a review of the literature. Mycoses2012; 56(2):110–6.
2.
KakourouTUksalU; European Society for Pediatric Dermatology. Guidelines for the management of tinea capitis in children. Pediatr Dermatol2010; 27(3):226–8.
3.
ElewskiBECáceresHWDeLeonL. Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. J Am Acad Dermatol2008; 59(1):41–54.
4.
DengSHuHAblizPWanZWangAChengWLiR. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China. Mycopath2011; 172(5):365–72.
5.
IwasawaMYorifujiKSanoATakahashiYNishimuraK. Case of kerion celsi caused by Microsporum gypseum (Arthroderma gypseum) in a child. Jpn J Med Mycol2009; 50 (3):155–60.
6.
UngpakornRAyutyanontTReangchainamSSupanyaS. Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine. Clin Exp Dermatol2004; 29 (3):300–3.
7.
SatoTIshiiKMorimotoASonobeAMotsuoI. A case of kerion celsi due to Microsporum gypseum responded well with itraconazole once weekly therapy. JPN J Clin Dermatol2004; 58:1065–67.
8.
HuangXWangFChenY. A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy. Future Microbiol2012; 7(2):201–9.
9.
GroverCAroraPManchandaV. Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis. Int J Dermatol2012; 51(4):455–8.
10.
SingalARawatSBhattacharyaSNMohantySBaruahMC. Clinico-myocological profile of tinea capitis in North India and response to griseofulvin. J Dermatol2001; 28 (1):22–6.
11.
Ginter-HanselmayerGSeebacherC. Treatment of tinea capitis - a critical appraisal. J Dtsch Dermatol Ges2011; 9(2):109–14.
12.
AsahinaATadaANakamuraKTamakiK. Griseofulvin has a potential to modulate the expression of cell adhesion molecules on leukocytes and vascular endothelial cells. Int Immunopharm2001; 1:75–83.
13.
ChiricozziAZhangSDattolaAGabelliniMChimentiSNisticòSP. Role of Th17 in the pathogenesis of cutaneous inflammatory diseases. J Biol Regul Homeost Agents2012; 26 (3):313–8.
14.
ChiricozziAZhangSDattolaACannizzaroMVGabelliniMChimentiSNisticòSP. New insights in the pathogenesis of cutaneous autoimmune disorders. J Biol Regul Homeost Agents2012; 26(2):165–70.
15.
SaracenoRNisticòSPCapriottiEChimentiS. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: A controlled study. Dermatol Ther2009; 22:391–94.
16.
SaracenoRNisticòSPCapriottiEde FeliceCRhodesLEChimentiS. Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis. Photodermatol Photoimmunol Photomed2009; 24:43–45.
17.
NisticòSChiricozziASaracenoRSchipaniCChimentiS. Vitiligo treatment with monochromatic excimer light and tacrolimus: Results of an open randomized controlled study. Photomed Laser Surg2012; 30:26–30.
18.
NisticòSPSaracenoRChiricozziAGiuntaADi StefaniAZerbinatiN. UVA-1 Laser in the treatment of palmoplantar pustular psoriasis. Photomed Laser Surg2013; 31:434–38.
